EUVIMEDEUVIMED entdecken
Crossref

Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas

Chunbaixue Yang, Bizhu Zhang, Jianchun Fan, Yixuan Zhang, Xinran Cao, Xueliang Wu, Tian Li iD

Postgraduate Medical Journal · 24.05.2026 · 102 (1209) · 633-644

DOI: 10.1093/postmj/qgaf237 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Postgraduate Medical Journal, online erschienen am 09.01.2026. Verfasst von Chunbaixue Yang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Graduate College, Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China. Hauptthemen laut MEDLINE: Vascular Cell Adhesion Molecule-1, Colorectal Neoplasms, Complement C1q, Adenoma. Die Arbeit nennt 35 Literaturangaben. Gefördert von: Hebei Province national college students innovation and entrepreneurship training project, Hebei North University Campus level Cultivation and Research Project, Graduate Innovation Funding Project in Hebei Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Colorectal cancer (CRC) screening is crucial for prevention. This study explored serum complement component 1q (C1QC) and vascular cell adhesion molecule-1 (VCAM-1) expression in CRC/polyp patients and their clinical significance for CRC diagnosis/staging.

Methods

Serum samples from 135 CRC patients, 135 polyp/adenoma patients, and 135 healthy controls (collected between 1 January 2023 and October 30 2023) were analyzed retrospectively. Data-independent acquisition proteomics identified differentially expressed proteins. C1QC and VCAM-1 levels were quantified via enzyme-linked immunosorbent assay. Diagnostic performance was evaluated via receiver operating characteristic curves and the area under the curve. Statistical analysis (SPSS 27.0, GraphPad Prism 9.5.1) included analysis of variance, Pearson correlation, and logistic regression (P < .05 was considered significant).

Results

C1QC and VCAM-1 levels were significantly greater in the CRC patient group than in the healthy/polyp group (P < .05), with no difference between the polyp and healthy groups (P > .05). Receiver operating characteristic analysis revealed that C1QC (cutoff: 52.34 μg/dl) and VCAM-1 (cutoff: 431.215 ng/ml) had 78.2% and 66.8% diagnostic accuracy, respectively. Combined detection achieved 80.2% accuracy, surpassing that of carcinoembryonic antigen/carbohydrate antigen 199. Both biomarkers increased with disease progression (P < .05) and aided staging assessment.

Conclusion

Serum C1QC and VCAM-1 demonstrate high diagnostic efficacy in CRC, correlate with pathological features, and hold promise as novel serological screening biomarkers.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Vascular Cell Adhesion Molecule-1Colorectal NeoplasmsComplement C1qAdenomaColonic PolypsHumansFemaleMaleMiddle AgedRetrospective StudiesBiomarkers, TumorROC CurveAgedCase-Control StudiesEnzyme-Linked Immunosorbent AssayNeoplasm StagingEarly Detection of Cancer

Stichwörter der Autor:innen

colorectal cancercomplement c1q c chaindiagnostic efficacyscreeningvascular cell adhesion molecule-1

Substanzen

Vascular Cell Adhesion Molecule-1Biomarkers, TumorComplement C1q

Autor:innen und Institutionen

  • Graduate College, Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
  • Department of Laboratory Medicine, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
  • Institute of Oncology, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
  • First Clinical Medical College, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
  • Department of General Surgery, The First Affiliated Hospital of Hebei North University, 11 Diamond South Road, Zhangjiakou 075000, Hebei Province, China.
  • Tianjin Key Laboratory of Acute Abdomen Disease-Associated Organ Injury and ITCWM Repair, Institute of Integrative Medicine of Acute Abdominal Diseases Tianjin Nankai Hospital, Tianjin Medical University, 8 Changjiang A…

ORCID-Profile: Tian Li

Förderung

  • Hebei Province national college students innovation and entrepreneurship training project
  • Hebei North University Campus level Cultivation and Research Project
  • Graduate Innovation Funding Project in Hebei Province
  • Postgraduate Education Project of Hebei North College
  • Hebei Provincial Natural Science Precision Medicine Joint Fund Project

Zitieren

APA

Yang, C., Zhang, B., Fan, J., Zhang, Y., Cao, X., Wu, X., & Li, T. (2026). Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas. Postgraduate Medical Journal, 102(1209), 633-644. https://doi.org/10.1093/postmj/qgaf237

Vancouver

Yang C, Zhang B, Fan J, Zhang Y, Cao X, Wu X, et al. Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas. Postgraduate Medical Journal. 2026;102(1209):633-644. doi:10.1093/postmj/qgaf237

BibTeX
@article{Yang2026,
  author = {Yang, Chunbaixue and Zhang, Bizhu and Fan, Jianchun and Zhang, Yixuan and Cao, Xinran and Wu, Xueliang and Li, Tian},
  title = {Levels and clinical significance of serum C1QC and VCAM-1 in patients with colorectal cancer or colorectal polyps/adenomas},
  journal = {Postgraduate Medical Journal},
  year = {2026},
  volume = {102},
  number = {1209},
  pages = {633--644},
  doi = {10.1093/postmj/qgaf237}
}
Kostenlos starten →